Universität zu Köln

Journal Article

Joerger, Markus, Cassier, Philippe, Penel, Nicolas, Cathomas, Richard, Richly, Heike, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Nogova, Lucia, Tai, David Wai-Meng, Sayehli, Cyrus, Gruellich, Carsten, Grande, Enrique, Navarro, Alejandra, Park, Se Hoon, Gillessen, Silke, Nogai, Hendrik, Bender, Sebastian, Ellinghaus, Peter and Schuler, Martin H. (2018). Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression. J. Clin. Oncol., 36 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Joerger, Markus, Cassier, Philippe Alexandre, Penel, Nicolas, Cathomas, Richard, Richly, Heike, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Nogova, Lucia, Tai, David Wai-Meng, Sayehli, Cyrus, Grullich, Carsten, Grande, Enrique, Navarro, Alejandro, Park, Se Hoon, Nogai, Hendrik, Bender, Sebastian, Ellinghaus, Peter and Schuler, Martin H. (2018). Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Schuler, Martin, Cho, Byoung Chuf, Sayehli, Cyrus Michael, Navarro, Alejandro, Soo, Ross A., Richly, Heike, Cassier, Philippe Alexandre, Tai, David, Penel, Nicolas, Nagoya, Lucia, Park, Se Hoon, Schostak, Martin, Gajate, Pablo, Cathomas, Richard, Rajagopalan, Prabhu, Grevel, Joachim ORCID: 0000-0002-4635-7211, Bender, Sebastian, Boix, Oliver, Nogai, Hendrik, Ocker, Matthias ORCID: 0000-0001-8263-6288, Eflinghaus, Peter and Joerger, Markus (2019). Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study. Lancet Oncol., 20 (10). S. 1454 - 1467. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Weihrauch, Martin R., Richly, Heike, von Bergwelt-Baildon, Michael S., Becker, Hans Jiro, Schmidt, Manuel, Hacker, Ulrich T., Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Holtick, Udo, Nokay, Bahar, Schroff, Matthias, Wittig, Burghardt and Scheulen, Max E. (2015). Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur. J. Cancer, 51 (2). S. 146 - 157. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852